Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA ‘Exception’ For Ipca’s Chloroquine/HCQ Amid Supply Plans From Others

Mar 24 2020

• By Anju Ghangurde

India — Temporary FDA Reprieve For IPA's Chloroquine, HCQ • Source: Shutterstock

Related Content

Ipca On Tailspin After Three-Plant FDA Ban

Jun 16 2017

Chloroquine Moves To Top of COVID-19 Clinical Trial List

Mar 20 2020

India COVID-19 Update: Antivirals, Eyes On HCQ-Azithromycin Data

Mar 22 2020

Related Companies

Ipca Laboratories Ltd.

Bayer AG

Pfizer Inc.

Cipla Limited

Alembic Pharmaceuticals Limited

Viatris Inc.

Novartis AG

Teva Pharmaceutical Industries Ltd.

Additional Topics

India Asia Pacific Regulation Coronavirus COVID-19 FDA BioPharmaceutical

More from India

More from Asia

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.